MICHELLE TOBIAS: Open Payments
NPI 1679022149 · ROOTSTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 17 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $932 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $77 |
| Lilly USA, LLC | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| PFIZER INC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Abbott Laboratories | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: Ozempic, MOUNJARO, TRELEGY ELLIPTA, NURTEC ODT, AIRSUPRA, Wegovy, ONZETRA XSAIL, FREESTYLE LIBRE 3.
Industry payments across OH — which companies pay providers there.
